September 9, 2024
TOPLINE: Adopting low-carbohydrate or low-fat diets over the short term doesn’t change gut-derived appetite hormones at the same levels as observed with pharmacologic treatments or bariatric […]
September 9, 2024
(Reuters) -Rezolute Inc said on Monday the U.S. Food and Drug Administration had lifted its partial clinical hold on a late-stage study testing the company’s treatment […]
September 9, 2024
(Reuters) -Terns Pharmaceuticals said its oral obesity drug reduced weight by an average of 4.9% in an early-stage study, joining drugmakers vying for a share of […]
September 9, 2024
Tirzepatide (Zepbound) is not in shortage for now, but the weight loss drug has remained inaccessible to people without insurance coverage who can’t afford to pay […]
September 9, 2024
TOPLINE: MADRID — In a rat study, two versions of an experimental monthly injectable semaglutide-loaded hydrogel show extended release over 1 month and good tolerance. If […]
September 6, 2024
TOPLINE: The metabolically unhealthy obesity phenotype, with its multiple comorbidities, may be the most practical group of people with obesity to screen for Cushing syndrome rather […]
September 6, 2024
(Reuters) – Eli Lilly’s experimental next generation weight-loss drug mimics three hormones instead of just one or two and continues to show promising clinical trial results […]
September 6, 2024
A so-called “oatzempic” diet has been bouncing around the internet posing as a cheap — and available — weight loss alternative to Ozempic. Fans of the […]
September 5, 2024
(Reuters) -In December, Drew, a 36-year-old man from San Antonio, Texas, drove more than 250 miles (400 km) to Mexico to buy cheap Ozempic to help […]